Literature DB >> 9843564

Decreases in organ blood flows associated with increases in sublingual PCO2 during hemorrhagic shock.

X Jin1, M H Weil, S Sun, W Tang, J Bisera, E J Mason.   

Abstract

Earlier studies demonstrated that not only the stomach but also the esophageal wall served as an appropriate site for estimating the severity of circulatory shock by using tonometric methods. We then conceived of the option of sublingual tonometry. In the present study, we tested the hypothesis that the changes in sublingual PCO2 serve as indicators of decreases in blood flow to sublingual and visceral tissue. In Sprague-Dawley rats, sublingual PCO2 increased from 50 to 127 Torr and arterial blood lactate increased from 0.9 to 11.2 mmol/l during bleeding. Sublingual blood flow simultaneously decreased to approximately 32% of preshock values. After reinfusion of shed blood, organ blood flows and sublingual PCO2 were promptly restored to near-baseline values. There were corresponding decreases in blood flows in the tongue, stomach, jejunum, colon, and kidneys during hemorrhagic shock. Increases in sublingual PCO2 were highly correlated with decreases in sublingual blood flow (r = 0.80), tongue blood flow (r = 0.81), gastric blood flow (r = 0.74), jejunal blood flow (r = 0.65), colon blood flow (r = 0.80), and renal blood flow (r = 0.75). Unbled control animals demonstrated no significant changes. Therefore, we anticipate that sublingual tonometry will provide a useful, noninvasive alternative for monitoring visceral PCO2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843564     DOI: 10.1152/jappl.1998.85.6.2360

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  13 in total

Review 1.  Monitoring CO2 in shock states.

Authors:  Pierre-Eric Danin; Nils Siegenthaler; Jacques Levraut; Gilles Bernardin; Jean Dellamonica; Karim Bendjelid
Journal:  J Clin Monit Comput       Date:  2014-11-13       Impact factor: 2.502

Review 2.  Noninvasive monitoring of peripheral perfusion.

Authors:  Alexandre Lima; Jan Bakker
Journal:  Intensive Care Med       Date:  2005-09-17       Impact factor: 17.440

Review 3.  Tissue capnometry: does the answer lie under the tongue?

Authors:  Alexandre Toledo Maciel; Jacques Creteur; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-10-02       Impact factor: 17.440

4.  Sublingual capnometry tracks microcirculatory changes in septic patients.

Authors:  Jacques Creteur; Daniel De Backer; Yasser Sakr; Marc Koch; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2006-02-17       Impact factor: 17.440

Review 5.  Resuscitating the microcirculation in sepsis: the central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials.

Authors:  Stephen Trzeciak; Ismail Cinel; R Phillip Dellinger; Nathan I Shapiro; Ryan C Arnold; Joseph E Parrillo; Steven M Hollenberg
Journal:  Acad Emerg Med       Date:  2008-05       Impact factor: 3.451

Review 6.  Regional capnometry to evaluate the adequacy of tissue perfusion.

Authors:  Stéphane Bar; Marc-Olivier Fischer
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

7.  The optimal endpoint of resuscitation in trauma patients.

Authors:  Paul E Marik
Journal:  Crit Care       Date:  2002-12-20       Impact factor: 9.097

8.  Esophageal capnometry during hemorrhagic shock and after resuscitation in rats.

Authors:  Balagangadhar R Totapally; Harun Fakioglu; Dan Torbati; Jack Wolfsdorf
Journal:  Crit Care       Date:  2002-12-20       Impact factor: 9.097

9.  Challenging the rationale of routine vasopressor therapy for management of hypotension.

Authors:  Max Harry Weil; Wanchun Tang
Journal:  Crit Care       Date:  2009-08-14       Impact factor: 9.097

10.  Monitoring Microcirculatory Blood Flow with a New Sublingual Tonometer in a Porcine Model of Hemorrhagic Shock.

Authors:  Péter Palágyi; József Kaszaki; Andrea Rostás; Dániel Érces; Márton Németh; Mihály Boros; Zsolt Molnár
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.